MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.
Massachusetts Institute of Technology (MIT) has launched an as-yet unnamed US-based spinout to commercialise a 3D-printable drug-delivery pill that would enable doctors to more effectively administer medication dosages, R&D Magazine has reported. The ingestible technology would remain in the patient’s stomach for almost a month, relying on its built-in sensors and wireless Bluetooth transmitters to…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
